Aptus Capital Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Buy
9,520
+810
+9% +$342K 0.03% 413
2026
Q1
$4.12M Buy
8,710
+5,479
+170% +$2.76M 0.03% 372
2025
Q4
$1.51M Buy
3,231
+170
+6% +$78.9K 0.01% 498
2025
Q3
$1.3M Sell
3,061
-7
-0.2% -$2.71K 0.01% 502
2025
Q2
$1.18M Buy
3,068
+78
+3% +$28.1K 0.01% 498
2025
Q1
$1.03M Sell
2,990
-24,238
-89% -$7.8M 0.01% 502
2024
Q4
$8.17M Buy
27,228
+24,947
+1,094% +$8.72M 0.09% 201
2024
Q3
$927K Sell
2,281
-23
-1% -$8.42K 0.01% 428
2024
Q2
$740K Buy
2,304
+314
+16% +$102K 0.01% 435
2024
Q1
$664K Buy
1,990
+995
+100% +$304K 0.01% 455
2023
Q4
$269K Buy
995
+5
+0.5% +$1.24K 0.01% 483
2023
Q3
$244K Buy
+990
New +$271K 0.01% 519

Other funds holding HCA

Aptus Capital Advisors's HCA Position: Q2 2026 in Review

Aptus Capital Advisors increased its HCA Healthcare (HCA) stake by 9.3% in Q2 2026, buying an estimated $342K and bringing the position to 9,520 shares worth $3.71M. The position accounts for 0.03% of the portfolio, ranked #413.

Aptus Capital Advisors first reported a position in HCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $8.17M in Q4 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Aptus Capital Advisors held 9,520 shares of HCA Healthcare worth $3.71M as of Q2 2026.
  • Aptus Capital Advisors bought 810 HCA Healthcare shares in Q2 2026, an estimated $342K.
  • HCA Healthcare made up 0.03% of Aptus Capital Advisors's portfolio in Q2 2026, its #413 holding.
  • Aptus Capital Advisors first reported a position in HCA Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Aptus Capital Advisors's HCA Healthcare position peaked at $8.17M in Q4 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.